IL134143A0 - Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs - Google Patents

Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs

Info

Publication number
IL134143A0
IL134143A0 IL13414398A IL13414398A IL134143A0 IL 134143 A0 IL134143 A0 IL 134143A0 IL 13414398 A IL13414398 A IL 13414398A IL 13414398 A IL13414398 A IL 13414398A IL 134143 A0 IL134143 A0 IL 134143A0
Authority
IL
Israel
Prior art keywords
monoclonal antibodies
vivo transformation
catalytic monoclonal
corticosteroid prodrugs
corticosteroid
Prior art date
Application number
IL13414398A
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Priority claimed from PCT/EP1998/004682 external-priority patent/WO1999006536A1/en
Publication of IL134143A0 publication Critical patent/IL134143A0/en

Links

IL13414398A 1998-07-27 1998-07-27 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs IL134143A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1998/004682 WO1999006536A1 (en) 1997-07-30 1998-07-27 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs

Publications (1)

Publication Number Publication Date
IL134143A0 true IL134143A0 (en) 2001-04-30

Family

ID=8167018

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13414398A IL134143A0 (en) 1998-07-27 1998-07-27 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs

Country Status (1)

Country Link
IL (1) IL134143A0 (en)

Similar Documents

Publication Publication Date Title
EP1073464A4 (en) Monoclonal antibodies with reduced immunogenicity
EP1180109A4 (en) Prodrug activation using catalytic antibodies
GB9809839D0 (en) Antibody
PL311926A1 (en) Anti-alphav-integrinic monoclonal antibodies
EP1110908A4 (en) Method for synthesis of hydroxyapatite, and hydroxyapatite complex and method for preparing the same
EP1030910A4 (en) Anti-cocaine catalytic antibody
EP1178829A4 (en) Human monoclonal antibody
IL206565A0 (en) An antibody immunospecific for an igs4 polypeptide
IL123888A0 (en) Anti-fas antibodies
HUP0003448A3 (en) Process for the combined preparation of fertilizers and sulfur compounds
EP0990701A4 (en) Monoclonal antibody against human telomerase catalytic subunit
EP1380646A4 (en) Acetyllysine-recognizing monoclonal antibody and process for producing the same
IL134143A0 (en) Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
PL346472A1 (en) High-affinity antibodies
EP1155056A4 (en) Method for the immobilization of oligonucleotides
AU5046700A (en) Diagnostic monoclonal antibody for LTiGTyersinia pestisLT/iGT
NO20000395L (en) Catalytic monoclonal antibodies for in vivo transformation of corticosteroid prodrugs
GB9828700D0 (en) Antibody
HUP0201987A2 (en) Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines
EP1109825A4 (en) Improved process for the synthesis of oligonucleotides incorporating 2-aminoadenosine
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin
HUP0101345A3 (en) Methods for enhancing the acid sites of fcc catalysts
GB9718911D0 (en) Monoclonal antibodies
HK1045989A1 (en) Method for the preparation of urea
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16